Pricing Log in Create free account

Connect Biopharma Holdings Limited Sponsored ADR (CNTB) vs Werewolf Therapeutics, Inc. (HOWL)

Connect Biopharma Holdings Limited Sponsored ADR and Werewolf Therapeutics, Inc. are both Biotechnology companies. Connect Biopharma Holdings Limited Sponsored ADR and Werewolf Therapeutics, Inc. are of similar size ($49.6M and $46.1M). Werewolf Therapeutics, Inc. has the higher net margin (−141.9% vs −2,298.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Werewolf Therapeutics, Inc. leads on 12 and Connect Biopharma Holdings Limited Sponsored ADR on 2.

Valuation

Metric CNTB HOWL Biotechnology median
P/E n/m n/m 10.60
P/S 15.30 1.99 9.40
P/B 1.71 2.98 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 4.87 1.98 9.02
Earnings yield (163.01%) (73.00%) (32.88%)
Free cash flow yield (132.91%) (61.47%) (23.13%)

Profitability

Metric CNTB HOWL Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (2,346.35%) (128.18%) 0.00%
Net margin (2,298.93%) (141.94%) 0.00%
Free cash flow margin (2,018.76%) (122.51%) 0.00%
Return on equity (140.51%) (119.86%) (51.96%)
Return on assets (109.34%) (59.31%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CNTB HOWL Biotechnology median
Revenue growth (TTM) — (5.21%) 6.76%
EPS growth (last fiscal year) (257.14%) 18.40% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTB HOWL Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 2.37 2.91 4.97
Net debt to EBITDA 0.77 0.97 1.01

Dividend

Metric CNTB HOWL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNTB HOWL Biotechnology median
Market cap 46.08m 49.57m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack